Evidence map›Paper›PMID 26833396›Full record

Trial reportTrials2016

Single-session gamified virtual reality exposure therapy for spider phobia vs. traditional exposure therapy: study protocol for a randomized controlled non-inferiority trial.

Alexander Miloff, Philip Lindner, William Hamilton, Lena Reuterskiöld, Gerhard Andersson, Per Carlbring

2 registry-linked trialsOpen access · goldAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 37 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 6 pooled it
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02533310 nacompletednot on this map

Single-session Gamified Virtual Reality Exposure Therapy for Spider Phobia vs. Traditional Exposure Therapy: a Randomized Controlled Non-inferiority Trial

TypeinterventionalSponsorStockholm UniversityRan2015 to 2019Enrolled100ConditionsPhobia, SpecificArmsOST treatment with in-vivo spiders, VR-OST treatment with virtual spiders
NCT04620447 phase1 / phase2completednot on this mapstarted 2018, after this paper: background citation

Development of Intelligent Virtual Reality Therapy System (IVRTS) and Testing Its Clinical Efficacy: Revolutionizing Evidence-Based Psychotherapy

TypeinterventionalSponsorUniversity College of Medical Sciences, IndiaRan2018 to 2020Enrolled500ConditionsPhobias, Acrophobia, AnxietyArmsIntelligent Virtual Reality Therapy System (IVRTS)
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 6 syntheses or guidelines pooled it, 139 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Extended reality for biomedicine.Nature reviews. Methods primers · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Alexander MiloffDepartment of Psychology, Stockholm University, Frescati Hagväg 8, 106 91, Stockholm, Sweden. alexander.miloff@psychology.su.se.
Philip LindnerDepartment of Psychology, Stockholm University, Frescati Hagväg 8, 106 91, Stockholm, Sweden. philip.lindner@ki.se.
William HamiltonDepartment of Psychology, Stockholm University, Frescati Hagväg 8, 106 91, Stockholm, Sweden. william@mimerse.com.
Lena ReuterskiöldDepartment of Psychology, Stockholm University, Frescati Hagväg 8, 106 91, Stockholm, Sweden. lsm@psychology.su.se.
Gerhard AnderssonDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. gerhard.andersson@liu.se.
Per CarlbringDepartment of Psychology, Stockholm University, Frescati Hagväg 8, 106 91, Stockholm, Sweden. per@carlbring.se.
Stockholm University · SELinköping University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTraditional one-session exposure therapy (OST) in which a patient is gradually exposed to feared stimuli for up to 3 h in a one-session format has been found effective for the treatment of specific phobias. However, many individuals with specific phobia are reluctant to seek help, and access to care is lacking due to logistic challenges of accessing, collecting, storing, and/or maintaining stimuli. Virtual reality (VR) exposure therapy may improve upon existing techniques by facilitating access, decreasing cost, and increasing acceptability and effectiveness. The aim of this study is to compare traditional OST with in vivo spiders and a human therapist with a newly developed single-session gamified VR exposure therapy application with modern VR hardware, virtual spiders, and a virtual therapist. METHODS/

designParticipants with specific phobia to spiders (N = 100) will be recruited from the general public, screened, and randomized to either VR exposure therapy (n = 50) or traditional OST (n = 50). A behavioral approach test using in vivo spiders will serve as the primary outcome measure. Secondary outcome measures will include spider phobia questionnaires and self-reported anxiety, depression, and quality of life. Outcomes will be assessed using a non-inferiority design at baseline and at 1, 12, and 52 weeks after treatment. DISCUSSION: VR exposure therapy has previously been evaluated as a treatment for specific phobias, but there has been a lack of high-quality randomized controlled trials. A new generation of modern, consumer-ready VR devices is being released that are advancing existing technology and have the potential to improve clinical availability and treatment effectiveness. The VR medium is also particularly suitable for taking advantage of recent phobia treatment research emphasizing engagement and new learning, as opposed to physiological habituation. This study compares a market-ready, gamified VR spider phobia exposure application, delivered using consumer VR hardware, with the current gold standard treatment. Implications are discussed.

trial registrationClinicalTrials.gov identifier NCT02533310. Registered on 25 August 2015.

Indexed as

Clinical ProtocolsPhobic DisordersSpidersVirtual Reality Exposure TherapyAdultAnimalsEquivalence Trials as TopicHumansOutcome Assessment, Health Care

Identifiers

PMID26833396
PMCPMC4736108
OpenAlexW2272558351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.